Hostname: page-component-6bf8c574d5-9nwgx Total loading time: 0 Render date: 2025-02-22T01:52:09.281Z Has data issue: false hasContentIssue false
  • English
  • Français

Impact of Anti-hypertensive Medication On Psychological Status and Quality of Life in Essential Hypertension

Published online by Cambridge University Press:  15 April 2020

E. Dragioti ,
D. Tsartsalis ,
K. Kontoangelos ,
M. Gouva ,
P. Sakkas ,
C. Papageorgiou  and
I. Kallikazaros
E. Dragioti
Affiliation:
Research Laboratory Psychology of Patients Families and Health Professionals, Higher Technological Educational Institution of Epirus, Ioannina, Greece
D. Tsartsalis
Affiliation:
Department of Cardiology, Hippokration Hospital, Athens, Greece
K. Kontoangelos
Affiliation:
First Department of Psychiatry, Eginition Hospital School of Medicine University of Athens, Athens, Greece
M. Gouva
Affiliation:
Research Laboratory Psychology of Patients Families and Health Professionals, Higher Technological Educational Institution of Epirus, Ioannina, Greece
P. Sakkas
Affiliation:
First Department of Psychiatry, Eginition Hospital School of Medicine University of Athens, Athens, Greece
C. Papageorgiou
Affiliation:
First Department of Psychiatry, Eginition Hospital School of Medicine University of Athens, Athens, Greece
I. Kallikazaros
Affiliation:
Department of Cardiology, Hippokration Hospital, Athens, Greece

Abstract

Background

Previous findings regarding a possible association among anti-hypertensive medication and dimensions of depressive symptoms, psychopathology and quality of life are mixed.

Objectives

This study examined whether anti-hypertensive medication impacts on depressive symptoms, psychopathology and quality of life in a sample of hypertensive patients.

Aims

Using a prospective design we aimed to explore the psychological status of hypertensive patients both at baseline and one year later.

Methods

A sample of 198 patients (89 men – 108 women, mean age 52, 9 years, SD = 11, 81 ranged 25-78) with a newly diagnosis of essential hypertension was recruited from a general hospital. The questionnaires included at baseline (T1): a) question for the recording of social-demographic characteristics and clinical features, b) The Short Form 36 (SF-36) General Health Survey questionnaire, c) the Beck Depression Inventory –II (BDI-II), and d) The Symptom Checklist-90-Revised (SCL-90-R). Sixty-two participants completed the SF-36, BDI-II and SCL-90-R again one year later (T2).

Results

Paired t tests showed that there were not significant differences on the psychological measures from baseline to one-year follow-up (Table 1).

Conclusions

Our findings do not support that anti-hypertensive medication has any impact on depression, general psychopathology and quality of life scores than those who use only a dietary program.

Type
Article: 0615
Information
European Psychiatry , Volume 30 , Issue S1: Abstracts of the 23rd European Congress of Psychiatry , March 2015 , pp. 1
Copyright
Copyright © European Psychiatric Association 2015
Submit a response

Comments

No Comments have been published for this article.